| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MRC Laboratory of Molecular Biology, Cambridge CB2 2QH, United Kingdom
Reprint requests to: Peter J. Lukavsky, MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK; e-mail: pjl{at}mrc-lmb.cam.ac.uk; fax: +44-1223-213556.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONRESULTS AND DISCUSSIONMATERIALS AND METHODSREFERENCES |
|---|
Keywords: IRES RNA; affinity chromatography; eukaryotic initiation factors; translation initiation; 48S complexes
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONRESULTS AND DISCUSSIONMATERIALS AND METHODSREFERENCES |
|---|
; Kapp and Lorsch 2004; Merrick 2004). The canonical pathway requires a 5'-capped mRNA and the full complement of eukaryotic initiation factors (eIFs) to coordinate 80S assembly. In a first step, eIF4G, eIF4E, eIF4A, and eIF4B mediate binding of the 43S particle—which consists of the small 40S ribosomal subunit, the ternary eIF2, GTP, Met-tRNAiMet complex, eIF3, eIF1A, and eIF1—to the 5' cap structure. The assembly then scans the 5' UTR to locate the first AUG start codon and to form a stable 48S complex, consisting of the 43S components properly assembled at the initiation codon. Subsequently, eIFs are released in a GTP-dependent manner, assisted by eIF5 and eIF5B, and the large 60S ribosomal subunit joins to form the active 80S ribosome. In contrast, some cellular mRNAs and several viral RNAs contain structured 5' UTRs, termed IRES elements, which mediate initiation without a 5' cap or scanning and use only a subset of eIFs to form a stable 48S complex.
Both initiation pathways have been studied by reconstituting 48S complexes in vitro using ribosomal subunits, Met-tRNAiMet, and eIFs purified from natural sources (Benne and Hershey 1978; Benne et al. 1979; Pestova et al. 1996; Algire et al. 2002). Using this approach, the roles of several eIFs during initiation have been elucidated, and the eIF requirements of several IRES RNAs have been characterized (for reviews, see Hershey and Merrick 2000; Pestova et al. 2001). Recently, an affinity-tagging method for the isolation of hepatitis C virus (HCV) IRES-mediated 48S initiation complexes from HeLa cell lysates has been presented as an additional tool to study 48S initiation complexes. In brief, RNA hairpin sequences, which form binding sites for the bacteriophage MS2 coat protein, are introduced upstream of the HCV IRES RNA. The hybrid RNA is incubated in the lysate, bound to amylose beads via a maltose-binding protein (MBP)–MS2 fusion protein, eluted with maltose after several washes, and fractionated on sucrose gradients. Using this method, the assembly of HCV IRES-mediated initiation complexes as well as assembly defects of mutant IRES RNAs could be studied (Ji et al. 2004).
Here we present a new affinity purification-based isolation procedure of 48S complexes from rabbit reticulocyte lysate (RRL) using the streptomycin-binding RNA aptamer (Bachler et al. 1999). The purification protocol was established using the HCV IRES RNA tagged at the 3' end. The initial affinity-based isolation of crude 48S complexes is followed by a final cleanup step using sucrose density gradient centrifugation and yields up to 1 mg of pure 48S complex from 10 mL of lysate. Quantitative Western and Northern blot analysis of the 48S particles suggested that eIF2 and eIF3 as well as Met-tRNAiMet are present in 1:1 stoichiometry with the 40S subunit, and toeprinting analysis showed proper assembly of the components at the AUG start codon. To demonstrate the versatility of the purification protocol, we further isolated 48S complexes using tagged, ß-globin mRNA (Dmitriev et al. 2003) and two different IRES RNAs from porcine teschovirus type 1 (PTV-1) (Pisarev et al. 2004) and encephalomyocarditis virus (EMCV) (Borovjagin et al. 1991).
|
RESULTS AND DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONRESULTS AND DISCUSSIONMATERIALS AND METHODSREFERENCES |
|---|
), then a short uracil–cytosine linker and the streptomycin aptamer sequence, the so-called StreptoTag (Bachler et al. 1999). We chose this simple affinity tag since it has been used previously to isolate RNA–protein complexes from cellular extracts with high specificity (Bachler et al. 1999). The RNA aptamer comprises <50 nt and binds dihydrostreptomycin coupled to a sepharose column matrix with micromolar affinity in a magnesium-dependent manner. In principle, the aptamer could therefore be eluted from the column upon addition of EDTA, but this would destabilize ribosomal particles. As an alternative elution method in the presence of magnesium, a buffer that contains streptomycin at a concentration of 10 µM can be used. Since eukaryotic ribosomes are naturally resistant to the antibiotic streptomycin (Chernoff et al. 1994), this method should allow elution of 48S complexes in the presence of stabilizing amounts of magnesium.
Compared with the previously published MBP–MS2 fusion protein-based HCV IRES 48S affinity purification, which used an RNA tag at the 5' end of the HCV IRES RNA, we attached the StreptoTag at the 3' end of the RNA. This should allow both the internal ribosome entry and scanning mode of initiation to occur on the tagged RNA oligonucleotides, since they contain a 5' end sequence that is not blocked by RNA hairpin sequences. In addition, placing the tag at the 3' end ensures that only full-length RNAs are bound to the affinity column. To minimize interference from the different coding regions with aptamer binding, we placed three UC repeats upstream of the aptamer as a short, presumably flexible linker. The length of the ORF was kept at ~85 nt to ensure proper spacing between the 48S particle and the StreptoTag. In addition, this length is ideal to detect inhibition of primer extension by reverse transcriptase (toeprinting) (Pestova et al. 1996), a method commonly used to test proper assembly of ribosomal initiation complexes (Hartz et al. 1988). To perform toeprinting, a primer needs to anneal to the ORF under the native condition within an intact 48S complex. Since strong secondary structure within the ORF could interfere with native binding, we engineered a unique, previously described primer site downstream of the individual ORF sequences (Pestova et al. 1996). To facilitate subcloning of several different IRES RNAs, we introduced an XbaI restriction site upstream of the toeprint primer site into the plasmid DNA template, so that individual IRES RNA elements could be subcloned between the HindIII and the XbaI sites (Fig. 1A). For tagged IRES RNAs, the full-length 5' UTR sequence was introduced together with the authentic ORF, since the first nucleotides of the coding sequence can be required for efficient IRES function (Reynolds et al. 1995). The tagged ß-globin mRNA comprised the full-length 5' UTR with a 5'-GGGAG sequence to allow efficient in vitro transcription using T7 polymerase and 54 nt of the coding sequence (Dmitriev et al. 2003). To introduce a 5' cap structure, transcription reactions were supplemented with m7G(5')ppp(5')GTP (Nielsen and Shapiro 1986).
|
), which contained the first 426 nt of genomic HCV RNA and was constructed as shown in Figure 1A. RRL was used as source of ribosomal subunits, initiation factors, and Met-tRNAiMet to assemble ribosomal complexes as previously described (Wilson et al. 2000). Briefly, RRL was treated with puromycin to part the ribosomal subunits and then was incubated in the presence of the non-hydrolyzable GTP analog, GMPPNP, to inhibit ribosomal subunit joining and to ensure a blockage of translation initiation events at the 48S stage (Merrick 1979). Then, tagged HCV IRES RNA was introduced to allow initiation complexes to form. After incubation, tagged HCV IRES RNA was bound to dihydrostreptomycin-coupled sepharose resin, washed, and released from the column by competitive elution with streptomycin (Fig. 2A). The elution fraction was then analyzed by native agarose gel electrophoresis and compared with purified ribosomal subunits. As shown in Figure 2B, the elution fraction contains the excess of tagged HCV IRES RNA. In agreement with the HCV IRES-mediated initiation pathway, the presence of binary complex between the small ribosomal subunit and the tagged HCV IRES RNA was also detected (Otto and Puglisi 2004). As expected, the eluted 48S particle migrated as a single band between the references of the large and the small ribosomal subunits. To further purify 48S complexes, HCV IRES-bound translation initiation complexes were pelleted by centrifugation and then fractionated using sucrose density gradient centrifugation, yielding separation between the free RNA, binary complexes, and 48S particles (Fig. 2C). As detected on native agarose gel electrophoresis (Fig. 2D), pure 48S complexes were obtained. Following this procedure, an input of 2 mg of tagged HCV IRES RNA and 10 mL of RRL yields up to 1 mg of 48S particle.
|
In order to block the translation initiation pathway at the 48S stage, we used a nonhydrolyzable GTP analog, GMPPNP, which inhibits the ribosomal subunit joining by preventing the hydrolysis of eIF2-bound GTP. This blocks the release of eIF2 from 48S complexes and therefore the subsequent joining of the 60S subunit to form 80S ribosomes (Merrick 1979). The purification of 48S complexes was performed either with or without GMPPNP. The resulting 48S particles were then assayed for the presence of eIF2 using Western blot analysis (Fig. 3A). When GMPPNP was omitted in the 48S assembly reaction, only a small amount of eIF2
could be detected within the 48S complexes, because GTP-dependent eIF2 release from the complex was not blocked during the assembly. The same Western blot performed on 48S complexes purified in the presence of GMPPNP shows a strong signal for eIF2, demonstrating efficient blockage of GTP-dependent eIF2 release and thereby translation initiation at the 48S stage.
|
or eIF3d subunits, respectively. About 20% of eIF2 and 35% of eIF3 present in the RRL were not incorporated into 48S particles and therefore were detected in the flow-through of the affinity column (Fig. 3B, lanes 1,2). Prolonged incubation time of the tagged HCV IRES RNA in the RRL did not alter the result (data not shown). No eIF2 and eIF3 was detected during the wash of the affinity column, indicating that the particle stayed intact, and ~80% of the amount of eIF2 and 65% of the amount of eIF3 initially present in the RRL could be detected in the elution fraction of the affinity column containing the 48S complexes (Fig. 3B, lanes 3,4). Also, during the next purification steps the particle stayed intact, since no eIF2 and eIF3 could be detected in the supernatant of the subsequent centrifugation step or in the top fractions of the final sucrose density gradient (Fig. 3B, lanes 5,7,8); only the 48S fractions contained the same amount of eIF2 and eIF3 as the initial elution fraction (Fig. 3B, cf. lanes 4 and 6). The presence of both eIF2 and eIF3 in the 48S particle, no losses of eIF2 or eIF3 during the individual purification steps, and the migration characteristics of the complex as a single peak in sucrose density gradients as well as a single band on native agarose gels (Fig. 2C,D) therefore strongly suggest that our purification protocol yields pure HCV IRES 48S particles containing the expected initiation factors (Pestova et al. 1998).
Assembly of 48S complexes at the initiation codon of an mRNA can be assessed using a so-called toeprinting assay, which directly identifies the position of the 40S subunit on the mRNA chain (Hartz et al. 1988). In a 48S complex, this arrest of reverse transcription occurs always at the same position 16–18 nt downstream of the adenine of the AUG start codon. Such a toeprint indicates that the start codon is placed in the P site of the small ribosomal subunit and is base-paired to charged Met-tRNAiMet (Hartz et al. 1988). 48S complexes assembled onto HCV IRES RNA using native Met-tRNAiMet and purified eIF2, eIF3, and 40S subunit yielded stops 16–18 nt downstream the AUG codon (Pestova et al. 1998). Toeprinting analysis of 48S complexes assembled onto HCV IRES RNA in GMPPNP-treated RRL yielded stops +16 and +17 nt downstream of the AUG codon (Otto and Puglisi 2004).
Toeprinting was used to assess the proper assembly of the isolated initiation complexes. First, 48S complexes were assembled onto tagged HCV IRES RNA in RRL in the presence of GMPPNP. Toeprints characteristic of a properly assembled 48S complex could be detected (Fig. 3C). The same toeprinting reaction was also carried out on the affinity-purified particles. The detection of the same stops at positions +16 and +17 nt downstream of the AUG demonstrated that our purification protocol yielded authentic 48S complexes with correct positioning of the AUG start codon within the ribosomal P-site (Fig. 3C).
To further confirm the suggested codon–anticodon base-pairing, we investigated whether Met-tRNAiMet is present in the purified 48S particle. Extraction of total RNA from the 48S complex was performed and then compared with an uncharged tRNAiMet transcript by Northern blot analysis using a probe complementary to the 3' end of tRNAiMet. As shown in Figure 3D, this experiment confirmed the presence of the tRNAiMet in our purified 48S complexes, consistent with the toeprinting results.
Our data demonstrate that eIF2, eIF3, and Met-tRNAiMet are present in the purified 48S complexes, and that Met-tRNAiMet is base-paired to the AUG start codon in the ribosomal P-site. To further assess the quality of the isolated particles, we performed quantitative Western and Northern blot analysis to also estimate the stoichiometry of the particle components. Serial dilutions of uncharged tRNAiMet ranging from 5–25 pMol and total RNA extracted from 15 pMol of HCV 48S particle were separated by denaturing PAGE, followed by Northern blot analysis and quantification of band intensities. As shown in Figure 4A, our measurements confirm that Met-tRNAiMet is present in the 48S particle in a 1:1 stoichiometry compared with 40S subunits. Since Met-tRNAiMet association with the 40S subunit withstands sucrose density gradient centrifugation, which was used as the final purification step, only in the presence of eIF2 (Unbehaun et al. 2004), the quantitative Northern analysis also strongly suggests that equimolar amounts of eIF2 are present in the particle. Quantitative Western blot analysis using serial dilutions of recombinant eIF2 and eIF3d over a linear range of 90–450 fMol and 6–90 pMol, respectively, indeed suggested the equimolarity of both eIF2 and eIF3 and the 40S subunits (Fig. 4B,C).
|
), reminiscent of the HCV IRES element. Toeprinting experiments performed on in vitro assembled initiation complexes suggested that PTV-1 IRES-mediated 48S complexes already form in the presence of only 40S subunits, eIF2, and Met-tRNAiMet (Pisarev et al. 2004). The presence of eIF3 in the complex only seemed to enhance the formation of the 48S-specific toeprint, suggesting that eIF3 might be an essential component of the PTV-1 IRES-mediated 48S particle. In order to test whether eIF3 is a component of the PTV-1 IRES 48S complex, we designed a tagged PTV-1 IRES RNA and assembled and purified initiation complexes using the protocol described above. Quantitative analysis again showed that, as for the tagged HCV IRES RNA, the 48S particle contains Met-tRNAiMet, eIF2, and eIF3d in equimolar amounts (Figs. 2D, 4). Our purification protocol is also applicable for IRES RNAs with different eIF-requirements, such as the IRES from the picornavirus EMCV (Jang et al. 1988). In contrast to PTV-1- and HCV IRES-mediated initiation, the EMCV IRES also requires the eIF4F complex and ATP-hydrolysis to assemble 48S complexes (Pestova et al. 1996). The assembly reaction in RRL using tagged EMCV IRES was therefore supplemented with ATP and the complex was purified as before, yielding homogeneous 48S particles (Figs. 2D, 4).
In addition to IRES-driven 48S assembly, we also tested whether our protocol is suitable for the assembly and isolation of canonical initiation complexes. Canonical initiation requires scanning of the 5' UTR, which should be possible with the affinity tag being placed at the 3' end of the mRNAs. In contrast to IRES-mediated initiation, cap-dependent initiation requires the full complement of initiation factors (Sachs et al. 1997; Kapp and Lorsch 2004; Merrick 2004). In order to validate our method for mRNAs, which initiate translation through the canonical pathway, we used a tagged ß-globin mRNA to isolate canonical 48S complexes. Once again, the 48S particle migrates as a single band on native agarose gels and contains equimolar amounts of Met-tRNAiMet, eIF3d, and eIF2, demonstrating that our protocol is suitable for purifying 48S complexes that require scanning during initiation.
Conclusion and outlook
We presented a novel, affinity chromatography-based method for the purification of eukaryotic 48S initiation complexes from RRL. Both canonical and diverse IRES-mediated 48S complexes could be purified in a quick, two-step procedure. The proper composition and stoichiometry of the components within the isolated particles was assessed by quantitative Northern and Western blot analysis, respectively. Our method can be used as a biochemical tool to study the initiation factor composition of 48S complexes assembled onto different cellular or viral IRES RNAs, as we demonstrated with the HCV, PTV-1, and EMCV IRES RNAs. This could complement approaches that use reconstitution of 48S particles from purified components. Isolation of 48S particles assembled onto mutant IRES RNAs could be used to study the effect of mutations on proper 48S assembly, initiation factor recruitment, or release. In addition, our purification scheme provides an efficient way to isolate milligram quantities of 48S complexes, which should benefit structural studies of eukaryotic initiation complexes.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONRESULTS AND DISCUSSIONMATERIALS AND METHODSREFERENCES |
|---|
). First, the Streptomycin aptamer with an upstream toeprint primer region was prepared using two primers (5' primer, GAGCTCTAGACGCCGAGATCAGAAATCCCTCTCTCGGATCGCATTTGGATTCTGCC; 3' primer, GCTCGAATTCGGATCCGACCGTGGTGCCCGAAGGCAGAAGTCCAATGCGATCC). The resulting PCR product was restriction digested with XbaI and EcoRI and ligated into pUC18 digested with the same enzymes. The purified vector (Strepto-vector) containing the StreptoTag and toeprint primer sequence was then used to subclone DNA inserts (containing a HindIII site, a T7 RNA polymerase promoter, the appropriate 5' UTR and coding sequence, and an XbaI site) between the HindIII and XbaI sites. The HCV IRES (GenBank database no. AF271632) insert corresponding to nucleotides 1–426, the PTV-1 IRES (Gen-Bank database no. AB038528) insert corresponding to nucleotides 3–479, and the ß-globin mRNA (Dmitriev et al. 2003) corresponding to nucleotides 1–107 with an additional 5' GGGAG sequence were prepared from overlapping primers. The resulting PCR products were restriction digested with HindIII and XbaI and ligated into the Strepto-vector digested with the same enzymes. The EMCV IRES insert corresponding to nucleotides 406–930 was amplified by PCR from a plasmid containing nucleotides 1–1740 (a kind gift from Richard Jackson, Cambridge University) using two primers (5' primer 5'-GAGCAAGCTTAATACGACTCACTATAGCATTCCTAGGGGTCTTTCC-3', 3' primer 5'-CTCGGCGTCTAGAGGTAAAATCCATTACGGTATTGTAGAGC-3'). The PCR product was restriction digested with HindIII and XbaI, yielding two fragments that were ligated into the Strepto-vector digested with the same enzymes. RNA oligonucleotides were transcribed from the above plasmids linearized with EcoRI (HCV IRES, EMCV IRES) or BamHI (PTV-1 IRES) using established protocols and purified by size-exclusion chromatography as described in Lukavsky and Puglisi (2004). The final RNA oligonucleotides were equilibrated into 10 mM Tris-HCl (pH 7.4) buffer using Centriprep centrifugal devices, concentrated to 0.5–1.0 A260 units per microliter, and stored at –20°C. ß-globin RNA was transcribed from the above plasmid linearized with EcoRI; a commercial cap structure analog, m7G(5')ppp(5')G (New England Biolabs) was included in the transcription reaction according to a published protocol (Nielsen and Shapiro 1986) to produce a 5'-capped ß-globin mRNA. The RNA was purified using the RNeasy Mini purification kit (Qiagen), equilibrated into 10 mM Tris-HCl (pH 7.4) buffer using Centriprep centrifugal devices, concentrated to 0.5–1.0 A260 units per microliter, and stored at –20°C.
Purification of factors and ribosomal subunits
DNA fragments encoding human eIF2 and eIF3d were prepared by PCR from cDNA libraries (Clontech) using primers 5'-CCAGGGTAGCCATATGCCGGGTCTAAGTTGTAGATTTTATC-3' and 5'-GGTGGTGCTCGAGTCATTAATCTTCAGCTTTGGCTTCCATTTCTTC-3' for eIF2 and 5'-CCAGGGTAGCCATATGGCAAAGTTCATGACACCCG-3' and 5'-GGTGGTGCTCGAGTCATTAAGTTTCTTCCTCTTCTTCTTCCTC for eIF3d, respectively. PCR products were digested with NdeI and XhoI and inserted into pET28a (Novagen) digested with the same enzymes to yield plasmids encoding His6-eIF2 and His6-eIF3d. Recombinant His6-eIF2 was expressed in Rosetta (DE3) cells (Novagen) and purified using HiTrap columns (Amersham) as previously described (Ito and Wagner 2004). Recombinant eIF3d was expressed in Rosetta (DE3) cells (Novagen) and purified under denaturing conditions using HIS-SELECT spin columns (Sigma) according to manufacturer instructions. The purity of both factors was assayed by Western blot analysis using specific antibodies and protein gel analysis, showing no apparent contamination.
Ribosomal subunits were purified according to published procedures (Pestova et al. 1996).
Affinity purification of initiation complexes
One milliliter (1 mL) of untreated RRL (Green Hectares) was incubated in 3 mL of binding buffer (10 mM MgCl2, 120 mM KCl, 8% sucrose, 20 mM Tris-HCl at pH 7.6) in the presence of 2.5 µL of ribonuclease inhibitor (Promega) and half a tablet of protease cocktail inhibitor (EDTA-free, Roche) for 10 min at 37°C. After incubation, puromycin was added (final concentration 1 mM), followed by 10 min incubation on ice and 10 min at 37°C. GMPPNP (Sigma; final concentration 2 mM) was added for an additional 5 min at 37°C. Then, tagged mRNA (final concentration 1 µM) was added, and incubation continued for another 10 min at 37°C. In addition, for the assembly of 48S complexes onto EMCV and ß-globin mRNA, 1 mM ATP was included to stimulate the scanning process. One gram (1 g) of dihydrostreptomycin-coupled sepharose 6B (Amersham), prepared as described in Bachler et al. (1999), was equilibrated with binding buffer at 4°C. Assembly reactions were then slowly loaded onto the column using a peristaltic pump while monitoring absorbance at 280 nm with a UV Monitor (UV-1, Amersham). A stable baseline was usually reached after washing with 10 column volumes of binding buffer at 4°C, and then the initiation complexes were eluted at room temperature with binding buffer containing streptomycin (final concentration 10 µM). Complexes were pelleted by centrifugation of the eluted fraction for 16 h at 45,000 rpm in a Ti90 rotor (Beckman). Ribosomal pellets were resuspended in 20 mM Tris-HCl (pH 7.6), 100 mM KOAc, 200 mM KCl, 2.5 mM MgCl2, 2 mM DTT, layered onto a 15%–40% sucrose density gradient in the same buffer, and centrifuged at 22,000 rpm in a Beckman SW28 rotor for 16 h at 4°C. 48S complexes were recovered by fractionating the gradient while monitoring absorbance at 260 nm. Each 1-mL fraction was analyzed on a 1% agarose gel using Tris-borate as running buffer at 4°C; the clean fractions were pooled, concentrated to a final concentration of 10 A260 units/mL using a YM-50 centricon (Millipore), and stored at –20°C. The same protocol was used to purify 48S complexes assembled onto PTV-1, EMCV, and ß-globin RNAs, except that ß-globin RNA ribosomal complexes were resuspended in 20 mM Tris-HCl (pH 7.6), 80 mM KCl, 2.5 mM MgCl2, 2 mM DTT, and purified through a sucrose gradient prepared in the same buffer conditions. All purified 48S complexes were finally analyzed on 1% native agarose gel.
Western blot analysis
Proteins from 0.05 A260 units of purified 48S particle were resolved by electrophoresis on 4%–12% NuPAGE gels (Invitrogen), transferred to nitrocellulose membranes, and blocked with 5% dry milk in PBS-Tween 0.2%. Membranes were then probed for eIF2 with monoclonal antibodies (Abcam, ab5369, dilution 1:2000) and eIF3d with polyclonal antibodies (PTGlab, 10219–1-AP, dilution 1:1000). Primary antibody binding was detected using appropriate HRP-coupled secondary antibodies (Abcam, ab6728 and ab6721, dilution 1:2000) and enhanced chemiluminescence (ECL reagent, Amersham) followed by PhosphorImager analysis.
To follow the presence of eIF2 and eIF3d through the purification process, equivalent volumes of each fraction (taking the different volumes of fractions into account compared with the initial volume of the assembly reaction) were loaded on a 12% NuPAGE gel.
Quantitative immunoblotting
Immunoblotting and detection by chemiluminescence were employed to quantify the level of eIF2 and eIF3d within 48S complexes assembled onto HCV, PTV-1, EMCV, and ß-globin mRNA. The concentrations of purified eIF2 and eIF3d were determined using extinction coefficients predicted from primary sequence and absorbance measurements at 280 nm of both proteins denatured in 6 M guanidinium chloride. Serial dilutions of purified eIF2 and eIF3d were loaded together with a fixed amount of 48S complexes with the extinction coefficient of the particle calculated from the three RNA components, the 18S rRNA, tRNAiMet, and tagged mRNA (1 A260 unit = 43 pMol). Quantitation of eIF2 and eIF3d over a linear range, 90–450 fMol and 6–90 pMol, was achieved using a standard dilution response curve constructed for each immunoblot. Quantitation of eIF2 and eIF3d was performed by comparing the band intensities on Hyperfilm ECL (Amersham). The photographic negatives of the immunoblots were scanned to a resolution of 600 dpi in grayscale mode. The scanned images were converted to histograms with ImageQuant software to plot the optical density as a response profile. The total optical density of individual bands was obtained by defining a rectangular area around each band and summing the total OD. To account for irregular baselines, sections of the same sizes as the integrated area were defined under the bands, and their intensity was subtracted. The intensity values were then normalized to that corresponding to a 1:1 stoichiometry within the 48S complexes and displayed as a percentage referred to this value. The values displayed correspond to the average of three independent experiments.
Primer extension analysis of ribosomal complexes
For toeprinting analysis of purified 48S particles, 0.2 A260 units of complexes were first exchanged into buffer A containing 5% sucrose, 2 mM DTT, 100 mM KOAc, 20 mM Tris (pH 7.6), 2.5 mM Mg(OAc)2, 0.1 mM GMPPNP, and 0.25 mM spermidine. Extension reactions were then carried out as follows: Ribosomal complexes were incubated for 3 min at 30°C and then 10 min on ice after adding 5 pmol of primer 5'-GGGATTTCTGATCTCGGCG-3' (Pestova et al. 1996). Then, final concentrations of 1 mM dNTPs, 5 mM Mg(OAc)2, 1 µL -32P ATP (3000 Ci/mmol; Amersham), and 0.7 U of avian myeloblastosis virus reverse transcriptase (Promega, 24 U/mL) were added and extension was performed for 45 min at 30°C. The mixtures were then carefully extracted with phenol to remove proteins. cDNA products were precipitated with ethanol overnight and analyzed on a 6% sequencing gel. Toeprinting analysis of translation initiation complexes assembled in RRL was performed as described previously (Wilson et al. 2000). Briefly, a master mix containing 15 µL RRL and 0.15 µL of ribonuclease inhibitor (Promega) was prepared. GMPPNP was added to a final concentration of 1 mM, and the mixtures were incubated for 5 min at 30°C, followed by the addition of 0.5 µg of mRNA and incubation for another 5 min at the same temperature. Mixtures were diluted to 40 µL in buffer A, and extension reactions were carried out and purified as above. cDNA products of the toeprinting reactions were compared with appropriate dideoxynucleotide sequence ladders performed on the unbound mRNA using the same primer.
Northern blot analysis
Total RNA was extracted from 0.25 A260 unit of purified 48S particle using the acetic acid/MgCl2 method (Hardy et al. 1969). The extracted RNAs were then separated using a 4% denaturing polyacrylamide gel together with in vitro transcribed tRNAiMet as a positive control (Pestova and Hellen 2001), then transferred to nylon membrane and blotted with 32P-labeled probe against the 3' end of tRNAiMet (5'-GGTAGCAGAGGATGGTTTCGATCC-3') using ExpressHyb solution (BD Biosciences). The results were visualized using a PhosphoImager.
To perform quantitative Northern blot analysis, serial dilutions of transcribed and purified tRNAiMet from 25 to 5 pMol were loaded on an 8% denaturing polyacrylamide gel together with 15 pMol of 48S complexes assembled onto HCV, PTV-1, ß-globin, and EMCV RNAs. The intensity of each band was quantified by PhosphorImager analysis using ImageQuant software. To account for irregular baselines, sections of the same sizes as the integrated area were defined under the bands and their intensity subtracted. The intensity values were then normalized to that corresponding to a 1:1 stoichiometry within the 48S complexes and displayed as percentage referred to this value. The values displayed correspond to the average of three independent experiments.
|
ACKNOWLEDGMENTS |
|---|
|
Footnotes |
|---|
Received September 13, 2005; accepted December 21, 2005.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONRESULTS AND DISCUSSIONMATERIALS AND METHODSREFERENCES |
|---|
Algire, M.A., Maag, D., Savio, P., Acker, M.G., Tarun Jr., S.Z., Sachs, A.B., Asano, K., Nielsen, K.H., Olsen, D.S., Phan, L., et al. 2002. Development and characterization of a reconstituted yeast translation initiation system. RNA 8: 382–397.[Abstract]
Bachler, M., Schroeder, R., and von Ahsen, U. 1999. StreptoTag: A novel method for the isolation of RNA-binding proteins. RNA 5: 1509–1516.[Abstract]
Benne, R. and Hershey, J.W. 1978. The mechanism of action of protein synthesis initiation factors from rabbit reticulocytes. J. Biol. Chem. 253: 3078–3087.
Benne, R., Brown-Luedi, M.L., and Hershey, J.W. 1979. Protein synthesis initiation factors from rabbit reticulocytes: Purification, characterization, and radiochemical labeling. Methods Enzymol. 60: 15–35.[Medline]
Borovjagin, A.V., Ezrokhi, M.V., Rostapshov, V.M., Ugarova, T., Bystrova, T.F., and Shatsky, I.N. 1991. RNA–protein interactions within the internal translation initiation region of encephalomyocarditis virus RNA. Nucleic Acids Res. 19: 4999–5005.
Chernoff, Y.O., Vincent, A., and Liebman, S.W. 1994. Mutations in eukaryotic 18S ribosomal RNA affect translational fidelity and resistance to aminoglycoside antibiotics. EMBO J. 13: 906–913.[Medline]
Dmitriev, S.E., Pisarev, A.V., Rubtsova, M.P., Dunaevsky, Y.E., and Shatsky, I.N. 2003. Conversion of 48S translation preinitiation complexes into 80S initiation complexes as revealed by toeprinting. FEBS Lett. 533: 99–104.[CrossRef][Medline]
Hardy, S.J., Kurland, C.G., Voynow, P., and Mora, G. 1969. The ribosomal proteins of Escherichia coli. I. Purification of the 30S ribosomal proteins. Biochemistry 8: 2897–2905.[CrossRef][Medline]
Hartz, D., McPheeters, D.S., Traut, R., and Gold, L. 1988. Extension inhibition analysis of translation initiation complexes. Methods Enzymol. 164: 419–425.[Medline]
Hershey, J.W.B. and Merrick, W.C. 2000. The pathway and mechansim of initiation of protein synthesis. In Translation control of gene expression (eds. N. Sonenberg et al.), pp. 33–88. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Ito, T. and Wagner, G. 2004. Using codon optimization, chaperone co-expression, and rational mutagenesis for production and NMR assignments of human eIF2. J. Biomol. NMR 28: 357–367.[Medline]
Jang, S.K., Krausslich, H.G., Nicklin, M.J., Duke, G.M., Palmenberg, A.C., and Wimmer, E. 1988. A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62: 2636–2643.
Ji, H., Fraser, C.S., Yu, Y., Leary, J., and Doudna, J.A. 2004. Coordinated assembly of human translation initiation complexes by the hepatitis C virus internal ribosome entry site RNA. Proc. Nat. Acad. Sci. 101: 16990–16995.
Kaku, Y., Chard, L.S., Inoue, T., and Belsham, G.J. 2002. Unique characteristics of a picornavirus internal ribosome entry site from the porcine teschovirus-1 talfan. J. Virol. 76: 11721–11728.
Kapp, L.D. and Lorsch, J.R. 2004. The molecular mechanics of eukaryotic translation. Annu. Rev. Biochem. 73: 657–704.[CrossRef][Medline]
Lukavsky, P.J. and Puglisi, J.D. 2004. Large-scale preparation and purification of polyacrylamide-free RNA oligonucleotides. RNA 10: 889–893.
Merrick, W.C. 1979. Evidence that a single GTP is used in the formation of 80 S initiation complexes. J. Biol. Chem. 254: 3708–3711.
———. 2004. Cap-dependent and cap-independent translation in eukaryotic systems. Gene 332: 1–11[CrossRef][Medline]
Nielsen, D.A. and Shapiro, D.J. 1986. Preparation of capped RNA transcripts using T7 RNA polymerase. Nucleic Acids Res. 14: 5936.
Otto, G.A. and Puglisi, J.D. 2004. The pathway of HCV IRES-mediated translation initiation. Cell 119: 369–380.[CrossRef][Medline]
Pestova, T.V. and Hellen, C.U. 2001. Preparation and activity of synthetic unmodified mammalian tRNAi(Met) in initiation of translation in vitro. RNA 7: 1496–1505.[Abstract]
Pestova, T.V., Hellen, C.U., and Shatsky, I.N. 1996. Canonical eukaryotic initiation factors determine initiation of translation by internal ribosomal entry. Mol. Cell. Biol. 16: 6859–6869.[Abstract]
Pestova, T.V., Shatsky, I.N., Fletcher, S.P., Jackson, R.J., and Hellen, C.U. 1998. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes & Dev. 12: 67–83.
Pestova, T.V., Kolupaeva, V.G., Lomakin, I.B., Pilipenko, E.V., Shatsky, I.N., Agol, V.I., and Hellen, C.U. 2001. Molecular mechanisms of translation initiation in eukaryotes. Proc. Nat. Acad. Sci. 98: 7029–7036.
Pisarev, A.V., Chard, L.S., Kaku, Y., Johns, H.L., Shatsky, I.N., and Belsham, G.J. 2004. Functional and structural similarities between the internal ribosome entry sites of hepatitis C virus and porcine teschovirus, a picornavirus. J. Virol. 78: 4487–4497.
Reynolds, J.E., Kaminski, A., Kettinen, H.J., Grace, K., Clarke, B.E., Carroll, A.R., Rowlands, D.J., and Jackson, R.J. 1995. Unique features of internal initiation of hepatitis C virus RNA translation. EMBO J. 14: 6010–6020.[Medline]
Sachs, A.B., Sarnow, P., and Hentze, M.W. 1997. Starting at the beginning, middle, and end: Translation initiation in eukaryotes. Cell 89: 831–838.[CrossRef][Medline]
Unbehaun, A., Borukhov, S.I., Hellen, C.U., and Pestova, T.V. 2004. Release of initiation factors from 48S complexes during ribosomal subunit joining and the link between establishment of codon-anticodon base-pairing and hydrolysis of eIF2-bound GTP. Genes & Dev. 18: 3078–3093.
Wilson, J.E., Pestova, T.V., Hellen, C.U., and Sarnow, P. 2000. Initiation of protein synthesis from the A site of the ribosome. Cell 102: 511–520.[CrossRef][Medline]
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
